Insider Trading History of Westby Keith

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Westby Keith since 2018. This trader's CIK number is 1696429. At the time of last reporting, Westby Keith was the SVP, Chief Operating Officer of Iveric Bio, Inc.. (stock ticker symbol ISEE). Also see all insider trading activities at Iveric Bio, Inc..



Yearly summary of insider trading at Iveric Bio, Inc. (ISEE) by Westby Keith

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 ISEE 0 $0 203,480 $6,204,822 162,048 $502,281
2022 ISEE 0 $0 184,098 $3,768,463 155,784 $174,671
2021 ISEE 0 $0 44,522 $587,949 67,500 $0
2020 ISEE 0 $0 8,496 $60,361 23,200 $0
2019 ISEE 0 $0 5,171 $30,710 13,981 $0
2018 ISEE 0 $0 673 $2,157 1,481 $0


Insider trading of Iveric Bio, Inc. (ISEE) by Westby Keith

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-07-03 ISEE Sale 20,000 39.45 789,000
2023-07-03 ISEE Option Ex 20,000 2.94 58,800
2023-06-02 ISEE Option Ex 20,000 2.94 58,800
2023-06-02 ISEE Sale 20,000 37.87 757,400
2023-05-02 ISEE Sale 20,000 37.81 756,200
2023-05-01 ISEE Sale 20,000 37.12 742,400
2023-05-02 ISEE Option Ex 20,000 2.94 58,800
2023-05-01 ISEE Option Ex 20,000 4.87 97,400
2023-04-24 ISEE Sale 18,782 30.07 564,774
2023-04-24 ISEE Option Ex 18,782 4.52 84,894
2023-04-21 ISEE Sale 1,218 30.00 36,540
2023-04-21 ISEE Option Ex 1,218 4.52 5,505
2023-04-03 ISEE Option Ex 40,000 2.97 118,800
2023-04-03 ISEE Sale 40,000 26.66 1,066,600
2023-03-02 ISEE Option Ex 13,298 1.45 19,282
2023-03-02 ISEE Sale 20,000 24.25 485,100
2023-02-02 ISEE Sale 20,000 23.82 476,400
2023-02-01 ISEE Sale 20,000 23.03 460,600
2023-01-02 ISEE Option Ex 8,750 .00 0
2023-01-03 ISEE Sale 3,480 20.06 69,808
2022-12-18 ISEE Option Ex 12,500 .00 0
2022-12-19 ISEE Sale 6,740 21.51 144,977
2022-12-12 ISEE Option Ex 12,500 .00 0
2022-12-09 ISEE Option Ex 10,000 .00 0
2022-12-13 ISEE Sale 6,741 21.73 146,481
2022-12-12 ISEE Sale 5,393 20.95 113,010
2022-12-02 ISEE Option Ex 5,199 10.03 52,145
2022-12-01 ISEE Sale 10,030 22.96 230,288
2022-11-01 ISEE Option Ex 42,916 1.45 62,228
2022-11-01 ISEE Sale 72,916 23.92 1,744,150
2022-04-18 ISEE Sale 10,000 16.63 166,300
2022-04-04 ISEE Option Ex 20,702 1.45 30,017
2022-04-05 ISEE Option Ex 9,298 1.45 13,482
2022-04-04 ISEE Sale 20,702 19.00 393,338
2022-04-05 ISEE Sale 9,298 19.02 176,810
2022-03-16 ISEE Sale 7,857 15.01 117,909
2022-03-17 ISEE Sale 2,143 15.06 32,280
2022-03-01 ISEE Option Ex 10,169 1.65 16,799
2022-02-15 ISEE Sale 10,000 15.16 151,630
2022-02-07 ISEE Sale 10,000 15.00 150,030
2021-12-31 ISEE Option Ex 32,500 .00 0
2022-01-03 ISEE Sale 12,278 16.39 201,260
2021-12-21 ISEE Sale 20,000 15.89 317,740
2021-12-18 ISEE Option Ex 12,500 .00 0
2021-12-20 ISEE Sale 4,516 15.44 69,745
2021-12-12 ISEE Option Ex 12,500 .00 0
2021-12-13 ISEE Sale 4,517 14.74 66,603
2021-12-10 ISEE Sale 3,614 14.53 52,518
2021-12-09 ISEE Option Ex 10,000 .00 0
2020-12-31 ISEE Option Ex 32,500 .00 0
2021-01-04 ISEE Sale 11,875 6.85 81,343
2020-12-12 ISEE Option Ex 12,500 .00 0
2020-12-14 ISEE Sale 4,527 7.16 32,413
2020-12-09 ISEE Option Ex 10,000 .00 0
2020-12-10 ISEE Sale 3,676 6.96 25,584
2020-01-04 ISEE Option Ex 700 .00 0
2020-01-06 ISEE Sale 293 8.07 2,364
2019-12-13 ISEE Sale 4,530 6.60 29,898
2019-12-12 ISEE Option Ex 12,500 .00 0
2019-01-07 OPHT Sale 299 1.30 388
2019-01-04 OPHT Option Ex 700 .00 0
2019-01-02 OPHT Option Ex 781 .00 0
2019-01-03 OPHT Sale 342 1.24 424
2018-01-05 OPHT Sale 317 3.17 1,004
2018-01-04 OPHT Option Ex 700 .00 0
2018-01-02 OPHT Option Ex 781 .00 0
2018-01-03 OPHT Sale 356 3.24 1,153

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Westby Keith (SVP, Chief Operating Officer of Iveric Bio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.